968 related articles for article (PubMed ID: 26857811)
1. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
2. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Geddes L; Iversen J; Wand H; Maher L
Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
[TBL] [Abstract][Full Text] [Related]
3. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
[TBL] [Abstract][Full Text] [Related]
4. Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?
Betts KS; McIlwraith F; Dietze P; Whittaker E; Burns L; Cogger S; Alati R
Drug Alcohol Depend; 2015 Sep; 154():76-84. PubMed ID: 26130335
[TBL] [Abstract][Full Text] [Related]
5. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.
Gjersing L; Bretteville-Jensen AL
Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019
[TBL] [Abstract][Full Text] [Related]
6. Is opioid substitution treatment beneficial if injecting behaviour continues?
Gjersing L; Bretteville-Jensen AL
Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
[TBL] [Abstract][Full Text] [Related]
7. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
8. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
9. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
10. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.
Bluthenthal RN; Simpson K; Ceasar RC; Zhao J; Wenger L; Kral AH
Drug Alcohol Depend; 2020 Jun; 211():107932. PubMed ID: 32199668
[TBL] [Abstract][Full Text] [Related]
11. Motivations, substance use and other correlates amongst property and violent offenders who regularly inject drugs.
Sutherland R; Sindicich N; Barrett E; Whittaker E; Peacock A; Hickey S; Burns L
Addict Behav; 2015 Jun; 45():207-13. PubMed ID: 25705014
[TBL] [Abstract][Full Text] [Related]
12. Overdose mortality rates in Croatia and factors associated with self-reported drug overdose among persons who inject drugs in three Croatian cities.
Handanagic S; Bozicevic I; Sekerija M; Rutherford GW; Begovac J
Int J Drug Policy; 2019 Feb; 64():95-102. PubMed ID: 30641451
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.
Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL
Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449
[TBL] [Abstract][Full Text] [Related]
14. Intravenous fentanyl use among people who inject drugs in Australia.
Geddes L; Iversen J; Memedovic S; Maher L
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465
[TBL] [Abstract][Full Text] [Related]
15. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
Horyniak D; Agius PA; Degenhardt L; Reddel S; Higgs P; Aitken C; Stoové M; Dietze P
Subst Use Misuse; 2015; 50(13):1650-9. PubMed ID: 26576630
[TBL] [Abstract][Full Text] [Related]
16. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with chronic pain and non-medical opioid use among people who inject drugs.
Bicket MC; Park JN; Torrie A; Allen ST; Weir BW; Sherman SG
Addict Behav; 2020 Mar; 102():106172. PubMed ID: 31704433
[TBL] [Abstract][Full Text] [Related]
18. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
19. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
[TBL] [Abstract][Full Text] [Related]
20. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Heidebrecht F; MacLeod MB; Dawkins L
Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
